Some plans cover them with prior authorization
The article says a provider should assess these before therapy begins, so a slower trajectory is recognized as a known interaction rather than mistaken for medication failure
doi: 10.3389/fsurg.2022.973883 Received 20 June 2022 Accepted 12 August 2022 Published 31 August 2022 Volume 9 - 2022 Edited by Pasquale Cianci, Azienda Sanitaria Localedella Provincia di Barletta Andri Trani (ASL BT), Italy Reviewed by Abdullah Ozgur Yeniova, Tokat Gaziosmanpaa University, Turkey Marina Minafra, Ospedale civile "Lorenzo Bonomo", Italy Updates Copyright 2022 Zhao, Chen, Xing, Yu and Liu
Anti-obesity medications: Drugs like lorcaserin and naltrexone can be used to target specific hormones or neurotransmitters involved in appetite regulation and energy balance
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: a report of five cases